NCT06247410View on ClinicalTrials.gov

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
Parkinson Disease
Interventions
DRUG

Rotigotine 8Mg/24Hrs Patch

Once daily patch application of one Rotigotine 8Mg/24Hrs Patch (Test or Reference) over 4 days

Trial Locations (8)

14547

Neurologisches Fachkrankenhaus für Bewegungsstörungen/ Parkinson, Beelitz-Heilstätten

35638

Gertrudis-Klinik Parkinson-Zentrum GmbH, Leun

63755

Neuroakademie Alzenau GbR, Alzenau in Unterfranken

77709

Parkinson-Klinik Ortenau GmbH & Co. KG, Wolfach

80331

Curiositas ad Sanum Studien- und Beratungs GmbH, München

83527

Curiositas ad Sanum Studien- und Beratungs GmbH Innklinikum Haag i.OB, Haag in Oberbayern

89081

Universitätsklinikum Ulm Neur. Studienzentrale im RKU, Ulm

07551

Praxis für Neurologie Dr. med. Christian Oehlwein, Gera

All Listed Sponsors
collaborator

SocraMetrics GmbH

INDUSTRY

collaborator

Luye Pharma Group Ltd.

INDUSTRY

lead

SocraTec R&D GmbH

OTHER

NCT06247410 - Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter